In Simple Terms
Bon Secours Mercy Health plans to buy a company that runs more than 200 surgery centers and other health facilities across 30 states for $5.7 billion. If the deal goes through in early 2027, the health system could earn more from care outside hospitals and gain a stronger hand in talks with insurers. The move reflects a broader shift toward doing some operations in lower-cost settings.
What’s Included in the Deal?
Bon Secours Mercy Health’s proposed purchase would give the health system a major foothold in outpatient surgery, a field that is taking on procedures once commonly performed in hospitals. On October 26, 2026, the nonprofit health system announced plans to buy Surgery Partners, a publicly traded company with operations across dozens of U.S. states. The announced price of $5.7 billion is about more than acquiring facilities: it signals a bet that both the location of care and the way it is paid for are changing quickly.
Surgery Partners operates more than 200 outpatient surgery centers, along with short-stay hospitals and multispecialty medical practices, across 30 states. That mix means the proposed deal would do more than add operating rooms to Bon Secours Mercy Health’s network. It would bring in a broader operating platform that combines surgical sites with medical services in several specialties.
Outpatient surgery centers are facilities where patients can have operations or other medical procedures without needing an extended hospital stay as part of their care. Short-stay hospitals serve patients who need to remain in a facility for a limited time, while multispecialty practices bring together doctors from different fields. Publicly available information does not break down how many of Surgery Partners’ facilities fall into each category or name the states where they operate. What is clear is the network’s size and its reach across 30 states.
The deal is expected to close in the first quarter of 2027, if the required steps proceed as planned. Until then, the expanded network remains an expected outcome, not a completed transaction. The $5.7 billion price tag indicates the scale of the agreement, but does not, by itself, reveal how the purchase will be financed, how ownership will be divided, or what operating terms will apply after it closes.
Why Are More Surgeries Moving Outside Hospitals?
The map of health care is changing as more procedures move to clinics and outpatient surgery centers. This shift is unfolding alongside changes in how some services are reimbursed under Medicare, the government program. Commercial insurers are also encouraging members to use settings considered less expensive than hospitals when the procedure is appropriate for that kind of facility.
For an insurer, directing a patient to a lower-cost facility may help reduce spending on certain operations. For a health system, specialized centers can be an attractive investment if demand grows and the facilities can be run efficiently. But lower costs do not mean that every procedure is suitable for an outpatient center, or that every patient can receive the same care at every location. Where an operation takes place still depends on the patient’s needs, the procedure involved, and the medical arrangements available.
Moving care does not eliminate the role of hospitals; it redistributes different kinds of care among different sites. Hospitals may continue to take patients who need more resources or longer stays, while other operations are performed in centers designed for people who do not need to remain for an extended period. The growth of outpatient surgery centers therefore reflects a change in how care is organized, not proof that hospitals will disappear or that all care will move out of them.
Profitability and Negotiating with Insurers
Owning a broad network of surgery centers could give a health system more opportunity to generate revenue from outpatient services, one reason operators are interested in these facilities. Based on information released about the deal, the acquisition is expected to improve Bon Secours Mercy Health’s profitability. That remains a projection, however, and depends on successfully integrating the two networks, managing the facilities, and sustaining demand for procedures performed outside hospitals.
Negotiations with insurers are another part of the story. A health system with more care sites may be in a stronger position when discussing service prices and coverage terms, because a larger network can give an insurer access to more facilities through a single agreement. But network size alone does not show whether insurance prices will rise or fall, and it does not guarantee that operating savings will reach patients. Those outcomes depend on contract details and prices that have not been included in the publicly announced information about the deal.
That is why it matters to distinguish the health system’s interests from patients’ interests. The acquisition could help Bon Secours Mercy Health expand and strengthen its commercial position, but that alone is not enough to determine what will happen to bills, access to care, or service quality. Those effects will depend on what happens after the deal closes, how the centers are run, and what agreements are reached with insurers.
A Nonprofit Health System and a Deal with a Business Case
Bon Secours Mercy Health is a Catholic nonprofit health system, while Surgery Partners is a publicly traded company. The proposed deal brings together two different types of organizations operating in a market where providing care is intertwined with pressure on revenue and costs. Nonprofit status does not mean a health system has no need for money or does not seek to improve its financial performance. Health systems need funding to run their operations and invest in facilities and services.
At the same time, the deal’s price does not reveal how the health system will balance patient care with financial considerations after the acquisition. The announced rationale is that the expansion could improve profitability and increase the system’s influence in negotiations with insurers. The public information does not spell out plans for changing services, staffing, or facility locations, so it would be premature to assume the purchase will necessarily lead to facilities closing, expanding, or changing how they operate.
The transaction is also connected to Bain Capital, a private equity firm, as Bon Secours Mercy Health is expected to become more closely connected with it. The available announcement does not explain the nature or terms of that relationship, but it highlights investor partnerships as part of the planned expansion. That matters because private equity firms are active in parts of the health care market, with facilities increasingly being bought and consolidated into larger networks.
A Bigger Push to Build Surgery-Center Networks
Bon Secours Mercy Health is not moving into this field alone. Earlier in 2026, the nonprofit health system Ascension bought AmSurg for $3.9 billion, bringing its network to about 300 outpatient surgery centers. That transaction is a clear sign that large health organizations—both nonprofit and for-profit—are competing to build a broader presence in care delivered outside hospitals.
The numbers differ across the two deals: Ascension’s purchase of AmSurg was valued at $3.9 billion, while Bon Secours Mercy Health plans to pay $5.7 billion for Surgery Partners. After its acquisition, Ascension’s network includes about 300 centers. Surgery Partners operates more than 200 outpatient surgery centers, as well as short-stay hospitals and multispecialty medical practices. Those figures alone do not allow for a precise comparison of the companies’ size or the value of each facility, because their services and asset mixes are not identical.
Even so, the transactions show that surgery centers have become an important part of health systems’ growth plans. Expansion can give them access to more markets and patients, and let them provide services at multiple sites rather than relying solely on hospitals. For insurers, a growing number of centers owned by large health systems could change the options available to patients and the way networks and prices are negotiated.
What to Watch Before the Deal Closes
The next key question is whether the deal will be completed on the expected schedule, in the first quarter of 2027. An announcement of plans to buy a company is not the same as a completed acquisition, and the transaction may depend on meeting relevant requirements and completing necessary steps. The available information does not provide a detailed timeline for those steps or other terms that would confirm the deal is certain to close on schedule.
After closing, integrating a network of more than 200 centers into a large health system will be a practical test of the organization’s ability to manage facilities spread across 30 states and coordinate them with its other services. Patients will want to know whether the centers remain available under their insurance plans and whether the expansion changes where operations are performed or what they cost. Insurers, too, will be watching how patients are distributed between hospitals and outpatient surgery facilities.
The financial questions matter as well: Will the expected profits materialize? And will savings from performing some procedures outside hospitals reduce what patients pay, or will they primarily improve the health system’s returns? The information available now does not answer those questions. Expected gains in profitability and negotiating power should not be treated as guaranteed results. Rather, they point to why the deal may appeal to the health system; its actual effects will become clearer as details of the integration emerge.
The Bottom Line
Bon Secours Mercy Health’s planned $5.7 billion purchase of Surgery Partners highlights a growing race to build large networks for surgical care outside hospitals. Surgery Partners operates more than 200 outpatient surgery centers and other facilities across 30 states, and the deal is expected to close in the first quarter of 2027. If completed, it could improve the health system’s profitability and strengthen its position in negotiations with insurers, while deepening its connection to Bain Capital. But the effects on patients, prices, and access to care remain uncertain. Alongside Ascension’s $3.9 billion purchase of AmSurg, which gave it about 300 centers, the deal suggests that more surgery may take place beyond hospital walls. How much patients benefit will depend on how these networks are run—and who ultimately gains from their savings.